Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
7.78
+0.14 (1.83%)
At close: Jul 31, 2026, 4:00 PM EDT
7.79
+0.01 (0.13%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $1.32 billion as of July 31, 2026. Its market cap has increased by 212.94% in one year.
Market Cap
1.32B
Enterprise Value
1.20B
1-Year Change
212.94%
Ranking
Category
Stock Price
$7.78
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.32B, an increase of 211.43%. That is a compound annual growth rate of 25.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.32B | 151.13% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.46B |
| Monte Rosa Therapeutics | 1.40B |
| ArriVent BioPharma | 1.39B |
| Savara | 1.38B |
| Avalyn Pharma | 1.28B |
| MannKind | 1.25B |
| Ardelyx | 1.22B |
| Aktis Oncology | 1.22B |